Abstract | PURPOSE: METHODS: We performed a prospective randomized non-inferiority trial comparing the use of sennoside and PEG in MBP for elective colon cancer surgery, in terms of the risk of surgical site infection (SSI) and the feasibility of surgery. RESULTS: The overall incidence of SSIs was 2.9 % in the sennoside group (n = 68) and 6.3 % in the PEG group (n = 63) with a difference of 3.4 % (95 % confidence interval 6.9-10.6 %). The intraoperative spillage of the stool materials in the sennoside and PEG groups was 4.4 and 3.1 %, respectively, and was not significantly different (p = 0.71), even the upstream stool consistency, was more frequently observed to be non-stool in the PEG group (65.1 vs. 30.9 %, p < 0.01). CONCLUSION:
|
Authors | Yusuke Tajima, Hideyuki Ishida, Azusa Yamamoto, Noriyasu Chika, Hisashi Onozawa, Takeaki Matsuzawa, Kensuke Kumamoto, Keiichiro Ishibashi, Erito Mochiki |
Journal | Surgery today
(Surg Today)
Vol. 46
Issue 6
Pg. 735-40
(Jun 2016)
ISSN: 1436-2813 [Electronic] Japan |
PMID | 26319220
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Cathartics
- Sennosides
- Polyethylene Glycols
- Senna Extract
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Cathartics
- Colonic Neoplasms
(surgery)
- Digestive System Surgical Procedures
(methods)
- Elective Surgical Procedures
(methods)
- Feasibility Studies
- Female
- Follow-Up Studies
- Humans
- Incidence
- Male
- Middle Aged
- Polyethylene Glycols
- Prospective Studies
- Risk
- Sample Size
- Senna Extract
- Sennosides
- Surgical Wound Infection
(epidemiology, prevention & control)
|